Solvent/detergent plasma: pharmaceutical characteristics and clinical experience
Open Access
- 21 May 2014
- journal article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 39 (1) , 118-128
Abstract
The solvent/detergent treatment is an established virus inactivation technology that has been industrially applied for manufacturing plasma derived medicinal products for almost 30 years. Solvent/detergent plasma is a pharmaceutical product with standardised content of clotting factors, devoid of antibodies implicated in transfusion-related acute lung injury pathogenesis, and with a very high level of decontamination from transfusion-transmissible infectious agents. Many clinical studies have confirmed its safety and efficacy in the setting of congenital as well as acquired bleeding disorders. This narrative review will focus on the pharmaceutical characteristics of solvent/detergent plasma and the clinical experience with this blood product.Keywords
This publication has 94 references indexed in Scilit:
- Recovery, safety, and tolerability of a solvent/detergent‐treated and prion‐safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteersTransfusion, 2013
- A comparison of methods of pathogen inactivation of FFPVox Sanguinis, 2011
- The Use of Solvent/Detergent Treatment in Pathogen Reduction of PlasmaTransfusion Medicine and Hemotherapy, 2011
- Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center ExperienceTransfusion Medicine and Hemotherapy, 2010
- The influence of riboflavin photochemistry on plasma coagulation factorsTransfusion and Apheresis Science, 2009
- Quality control of recovered plasma for fractionation: an extensive Italian studyTransfusion, 2008
- Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalenTransfusion, 2007
- Toward Rational Fresh Frozen Plasma TransfusionAmerican Journal of Clinical Pathology, 2006
- Acute hyperphosphatemia after plasma exchange with S/D‐treated plasmaTransfusion, 2004
- Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinationsTransfusion, 1985